Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-22-037 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications focused on advancing development of vaccine candidates against Enterotoxigenic Escherichia coli (ETEC), Salmonella enterica serotype Paratyphi A, and two Shigella species, Shigella flexneri and S. sonnei. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 10, 2022 Category: Research Source Type: funding
Cooperative Agreement to Support the North Carolina State University, Prestage Department of Poultry Science and the Piedmont Research Station (U01)
Funding Opportunity Number: RFA-FD-13-031 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: Other (see text field entitled "Explanation of Other Category of Funding Activity" for clarification)CFDA Number: 93.103Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-FDAClosing Date: Jul 15, 2013Award Ceiling: $50,000Expected Number of Awards: 1Creation Date: Jun 21, 2013Funding Opportunity Description: The Food and Drug Administration (FDA) is announc...
Source: Grants.gov - July 31, 2013 Category: Research Tags: Other (see text field entitled Explanation of Other Category of Funding Activity for clarification) Source Type: funding
